Children 0 8 0 8 O
( 9 10 9 10 O
age 10 13 10 13 B-age
< 14 15 14 15 O
18 16 18 16 18 B-upper_bound
) 18 19 18 19 O

Clinical 0 8 20 28 O
or 9 11 29 31 O
pathological 12 24 32 44 O
evidence 25 33 45 53 O
of 34 36 54 56 O
distant 37 44 57 64 B-cancer
metastases 45 55 65 75 I-cancer
( 56 57 76 77 O
M1 57 59 77 79 O
) 59 60 79 80 O

History 0 7 81 88 O
of 8 10 89 91 O
prior 11 16 92 97 B-treatment
chemotherapy 17 29 98 110 I-treatment

History 0 7 111 118 O
of 8 10 119 121 O
prior 11 16 122 127 B-treatment
pelvic 17 23 128 134 I-treatment
radiation 24 33 135 144 I-treatment
therapy 34 41 145 152 I-treatment

Karnofsky 0 9 153 162 B-clinical_variable
Performance 10 21 163 174 I-clinical_variable
Scale 22 27 175 180 I-clinical_variable
> 28 29 181 182 O
70 30 32 183 185 B-lower_bound
( 33 34 186 187 O
Appendix 34 42 187 195 O
II 43 45 196 198 O
) 45 46 198 199 O

No 0 2 200 202 O
evidence 3 11 203 211 O
of 12 14 212 214 O
distant 15 22 215 222 B-cancer
metastases 23 33 223 233 I-cancer
( 34 35 234 235 O
Bone 35 39 235 239 B-treatment
scanning 40 48 240 248 I-treatment
) 48 49 248 249 O

No 0 2 250 252 O
prior 3 8 253 258 B-treatment
pelvic 9 15 259 265 I-treatment
or 16 18 266 268 I-treatment
prostate 19 27 269 277 I-treatment
radiation 28 37 278 287 I-treatment
or 38 40 288 290 O
chemotherapy 41 53 291 303 B-treatment
for 54 57 304 307 O
any 58 61 308 311 O
reason 62 68 312 318 O
; 68 69 318 319 O

Prostate 0 8 320 328 B-treatment
tumor 9 14 329 334 I-treatment
biopsy 15 21 335 341 I-treatment
grading 22 29 342 349 O
by 30 32 350 352 O
Gleason 33 40 353 360 B-clinical_variable
score 41 46 361 366 I-clinical_variable
classification 47 61 367 381 O
is 62 64 382 384 O
mandatory 65 74 385 394 O
prior 75 80 395 400 O
to 81 83 401 403 O
registration 84 96 404 416 O
( 97 98 417 418 O
Appendix 98 106 418 426 O
V 107 108 427 428 O
) 108 109 428 429 O

Radical 0 7 430 437 B-treatment
surgery 8 15 438 445 I-treatment
for 16 19 446 449 O
carcinoma 20 29 450 459 B-cancer
of 30 32 460 462 I-cancer
the 33 36 463 466 I-cancer
prostate 37 45 467 475 I-cancer

T1 0 2 476 478 B-cancer
- 2 3 478 479 I-cancer
2N0M0 3 8 479 484 I-cancer
with 9 13 485 489 O
risk 14 18 490 494 O
of 19 21 495 497 O
pelvic 22 28 498 504 B-clinical_variable
lymph 29 34 505 510 I-clinical_variable
nodes 35 40 511 516 I-clinical_variable
involvement 41 52 517 528 I-clinical_variable
> 53 54 529 530 O
25 54 56 530 532 B-lower_bound
% 56 57 532 533 I-lower_bound
by 58 60 534 536 O
Roach 61 66 537 542 O
formula 67 74 543 550 O
[ 75 76 551 552 O
( 76 77 552 553 O
2/3xPSA 77 84 553 560 O
) 84 85 560 561 O
+ 86 87 562 563 O
( 88 89 564 565 O
Gleason 89 96 565 572 O
Score 97 102 573 578 O
- 103 104 579 580 O
6)x10 105 110 581 586 O
] 110 111 586 587 O
, 111 112 587 588 O
or 113 115 589 591 O
any 116 119 592 595 O
T3 120 122 596 598 B-cancer
- 122 123 598 599 I-cancer
4N0M0 123 128 599 604 I-cancer

adenocarcinoma 0 14 605 619 B-cancer
of 15 17 620 622 O
the 18 21 623 626 O
prostate 22 30 627 635 O

induction 0 9 636 645 B-treatment
hormonal 10 18 646 654 I-treatment
therapy 19 26 655 662 I-treatment
prior 27 32 663 668 O
to 33 35 669 671 O
registration 36 48 672 684 O
is 49 51 685 687 O
acceptable 52 62 688 698 O

